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Human UMP/CMP kinase plays a crucial role in sup-
plying precursors for nucleic acid synthesis by cata-
lyzing the conversion of UMP, CMP, and dCMP into
their diphosphate form. In addition, this kinase is an
essential component of the activation cascade of medic-
inally relevant nucleoside analog prodrugs such as
AraC, gemcitabine, and ddC. During the catalytic cycle
the enzyme undergoes large conformational changes
from open in the absence of substrates to closed in the
presence of both phosphoryl donor and phosphoryl ac-
ceptor. Here we report the crystal structure of the sub-
strate-free, open form of human UMP/CMP kinase. Com-
parison of the open structure with the closed state
previously reported for the similar Dictyostelium discoi-
deum UMP/CMP kinase reveals the conformational
changes that occur upon substrate binding. We observe
a classic example of induced fit where substrate-induced
conformational changes in hinge residues result in rigid
body movements of functional domains to form the cata-
lytically competent state. In addition, a homology model
of the human enzyme in the closed state based on the
structure of D. discoideum UMP/CMP kinase aids to ra-
tionalize the substrate specificity of the human enzyme.
UMP/CMP kinase plays a critical role in the pathway that
supplies nucleotide precursors for DNA and RNA synthesis.
The physiological substrates UMP, CMP, and dCMP are re-
versibly converted by UMP/CMP kinase into their diphosphate
form according to the following reaction scheme.
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Subsequent phosphorylation by nucleoside diphosphate ki-
nase results in the triphosphorylated form of these nucleotides,
which are the substrates for DNA and RNA polymerases. Ad-
ditionally, UMP/CMP kinase participates in the activation of
clinically relevant nucleoside analog prodrugs that are used in
cancer and viral chemotherapy. Therefore, understanding the
determinants of substrate specificity, the precise roles played
by its catalytic residues, and the conformational changes that
take place during the catalytic cycle is of paramount impor-
tance for the development of more effective anti-cancer and
anti-viral agents.
Despite the physiological and medicinal importance of this
enzyme, the human form was cloned only in 1999 (1). This work
was followed by biochemical characterization of the enzyme,
which revealed its ability to phosphorylate synthetic nucleo-
sides (2–4). Important examples are the monophosphate form
of the cytidine analogs 1--D-arabinofuranosylcytosine (AraC)1
and 2,2-difluorodeoxycytidine (gemcitabine), a mainstay of
leukemia and lymphoma therapy. The first step in the conver-
sion of these cytidine analogs to their pharmacologically active
triphosphorylated form is catalyzed by deoxycytidine kinase.
We have recently published the structure of human deoxycyti-
dine kinase in complex with AraC, gemcitabine, and its phys-
iological substrate deoxycytidine (5). The second step of AraC
and gemcitabine activation, from the monophosphate to the
diphosphate form, is catalyzed by UMP/CMP kinase. The third
phosphate group is added by the non-base-specific nucleoside
diphosphate kinase. In addition, UMP/CMP kinase has the
remarkable ability to phosphorylate L-nucleotides (3). Of spe-
cial importance is 3TC (-L-2,3-dideoxy-3-thiacytidine) used
in the treatment of human immunodeficiency virus infection.
However, prior to this work, our structural understanding of
this important enzyme was limited to the yeast uridylate ki-
nase (6) (50% sequence identity to the human enzyme) and the
UMP/CMP kinase from the slime mold Dictyostelium discoi-
deum (52% identity) (7). Here we present the structure of the
human UMP/CMP kinase in its apo conformation.
UMP/CMP kinase belongs to the nucleoside monophosphate
(NMP) kinase family that includes adenylate kinase, guanylate
kinase, and thymidylate kinase. All of these globular proteins
contain a typical / fold that consists of a -sheet core sur-
rounded by -helices, with the P-loop motif at the N terminus
that binds the phosphoryl donor (in general ATP). Previous struc-
tural studies on these enzymes revealed considerable conforma-
tional changes that occur in response to substrate binding (8).
These conformational changes can be described as the rigid body
movement of regions referred to as the NMP-binding and LID
regions relative to the CORE domain. The substrate-free enzyme
is characterized by a more “open” state where the LID, which
typically contains catalytic residues, is most distant from the
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NMP-binding region. Upon binding of one the substrates, an
intermediate “partially closed” state is formed. Only in the pres-
ence of both nucleotides do these enzymes adopt the “closed” (and
active) conformation that is characterized by the LID region
interacting with the substrate at the phosphoryl donor site.
There is no single NMP kinase of the same organism for
which all of the above states have been observed. Because of
pronounced enzyme flexibility, it has been difficult to obtain
crystal structures of NMP kinases in the absence of ligands
that act to stabilize a conformation compatible with crystal
growth. In the case of UMP/CMP kinase, all of the structures
solved of the yeast and mold enzymes contain substrates or
inhibitor occupying both donor and acceptor sites (6, 7, 9–11).
Surprisingly, we were able to grow crystals of human UMP/
CMP kinase that diffracted to high resolution in the absence of
substrates. Comparison of this structure with the homologous
D. discoideum enzyme reveals the considerable conformational
changes that occur upon substrate binding. Here we analyze
these conformational changes. In addition, we have built a
homology model of the closed form of human UMP/CMP kinase
and use this model to analyze the substrate specificity of the
human enzyme.
EXPERIMENTAL PROCEDURES
Cloning and Expression of UMP/CMP Kinase—Using a commercially
available brain tissue cDNA library (Invitrogen) as template, we re-
trieved by standard PCR procedures the 588-bp DNA fragment corre-
sponding to the coding region of the so-called “short” form of human
UMP/CMP kinase. This 196-residue protein was reported to represent
the physiological form of the enzyme in human cells (3). Primer oligo-
nucleotides were designed based on the published DNA sequence (1)
introducing suitable endonuclease restriction sites at either end to
facilitate direct cloning into the pGEX-RB bacterial expression vector
(12): sense primer, 5-GGAATTCCATATGAAGCCGCTGGTCGTGTT-
C-3 (NdeI restriction site underlined; ATG codon of the first Met
residue in bold letters); antisense primer, 5-CGGGATCCTTAGCCTT-
CCTTGTCAAAAATCTG-3 (BamHI site underlined). Clone integrity
was verified by automatic DNA sequencing. Expression of the glutathi-
one S-transferase fusion protein in the Escherichia coli BL21(DE3)
strain was induced with 0.1 mM isopropyl-thio--D-galactopyranoside,
and the cells were grown14 h after induction at 22 °C in 2YT medium.
Protein Purification and Nucleotide Kinase Activity Measure-
ments—A purification protocol was developed that included a glutathi-
one-Sepharose column (Amersham Biosciences) and elution of the fu-
sion protein from the column with 10 mM glutathione in 200 mM KCl
and 10 mM Tris/HCl, pH 8.0. The glutathione S-transferase tag was
cleaved with thrombin (SERVA) while dialyzing against 200 mM of KCl,
25 mM Tris/HCl, pH 8.0, 8 mM -mercaptoethanol. After cleavage and
dialysis, the glutathione S-transferase was removed by loading for a
second time on the glutathione-Sepharose column. The UMP/CMP ki-
nase obtained from the previous step was further purified using gel
filtration (S75; Amersham Biosciences), in which it eluted as a single
peak of 22 kDa, consistent with a monomer being the physiological form
of this enzyme. The protein was stored frozen at 80 °C until used for
crystallization experiments.
Enzymatic activity in the forward reaction (ATP and UMP as sub-
strates) was determined at 25 °C in the spectrophotometer using an
NADH-dependent assay as described for TMP kinase (12). To probe
enzyme activity, characteristic steady state kinetic parameters were
determined, keeping the ATP concentration constant at 2 mM and
varying UMP between 10 M and 1 mM, in the presence of 5 mM
dithiothreitol. No substrate inhibition of the enzyme (varied from 1 to 5
g/ml of reaction volume) was observed in this range of UMP concen-
trations. The observed maximum activity for UMP phosphorylation was
180 mol/mg of enzyme/min, and the Km value was 30 M. The bisub-
strate analog P1-(5-adenosyl)-P5-(5-uridyl)pentaphosphate (UP5A)
(Jena Biosciences) was found to be a very strong inhibitor. At the
constant ATP concentration of 2 mM, the apparent UP5A inhibition
constant, Ki, was estimated to lie in the 1–5 nM range.
2 This value is
very close to that reported for the D. discoideum enzyme (dissociation
constant of 3 nM) (13).
Crystallization, X-ray Data Collection, and Structure Solution—Prior
to crystallization, the protein was dialyzed against a solution contain-
ing 25 mM KCl, 10 mM Hepes, pH 7.5, and 5 mM dithiothreitol. The
crystals were grown at room temperature using hanging drops contain-
ing equal volumes of protein and reservoir solutions. The protein solu-
tion contained 17 mg/ml of UMP/CMP kinase, 5 mM MgCl2, and either
4 mM AppNHp and 2 mM UMP or 1 mM UP5A, whereas the reservoir
contained 25% polyethylene glycol 4000, 0.2 M MgSO4, and 0.1 M sodium
acetate, pH 4.6. Hexagonal crystals appeared after 1–2 days. The crys-
tals were frozen by direct immersion in liquid nitrogen after a short
soak in the mother liquor that was complemented with 10% xylitol and
10% of sucrose as cryoprotectants. X-ray data were collected at the
Advanced Photon Source (Argonne National Laboratories) using the
SER-CAT (Southeast Regional Collaborative Access Team) beamline.
Data of high completeness and a signal-to-noise above 2 were collected
to 2.1 Å and processed with XDS (14). For molecular replacement, we
used the model of the D. discoideum UMP/CMP kinase in complex with
UP5A (7). A model of human UMP/CMP kinase in the closed conforma-
tion was generated using the protein structure homology modeling
server Swiss Model (15).
Structure Comparison and Conformational Change Analysis—The
structure comparison techniques used here have been previously de-
scribed by Gerstein and Chothia (16) and Lesk and Chothia (17) and
include the sieve fit, fit and refit, and fit all procedures. The conforma-
tional change analysis was done using the C atoms. We used the
program O for graphical analysis (18) and the program LSQMAN
(x-ray.bmc.uu.se/usf) for calculating distances between equivalent C
atoms in different structures and for rmsd analysis. Based on this
information, we identified hinge residues. The CCP4 supported pro-
gram POLYPOSE (19) was used to obtain the rotation matrix and
rotation values required for superimposing secondary structural ele-
ments between the open and closed conformational states.
RESULTS
Structure Solution—Human UMP/CMP kinase crystallized
in the hexagonal space group P6522 with a single molecule in
the asymmetric unit. Crystals were grown in the presence of
substrate or the bisubstrate inhibitor UP5A. Therefore, we
expected that the structural model of the closed conformation of
the D. discoideum enzyme complexed with UP5A (7) would be
appropriate for molecular replacement. Using Molrep (20) we
obtained a solution, but the crystallographic R factor was un-
expectedly high (56%). This was consistent with poor electron
density for considerable sections of the model. Nevertheless,
because of the rather high resolution limit of the data, we
decided to attempt automatic model building using the warpN-
trace mode of Arp (21). This worked astonishingly well yielding
a model missing only 12 of the 196 amino acids with a low
crystallographic R factor.
Upon inspection of the model built by Arp, we were much
surprised to observe a very different conformation of the en-
zyme compared with our search model. The Arp model revealed
UMP/CMP kinase in an open conformation (Fig. 1). No electron
density for the substrates could be observed. A strong peak of
electron density close to the P-loop was interpreted as a sulfate
ion; this is analogous to the sulfate ion observed in the apo-
adenylate kinase structure (22).
Quality of the Structure—Cycles of manual rebuilding reit-
erated with refinement using Refmac (23) and addition of wa-
ter molecules using Arp resulted in the final model with an
Rwork value of 22% and an Rfree value of 27%. In addition to 111
water molecules, all but the two most N-terminal residues, for
which no electron density was observed, were modeled. A single
sulfate ion is modeled bound to the P-loop main chain nitrogen
atoms. All main chain dihedral angles are found in the allowed
regions of the Ramachandran plot; the average B factor is 44
Å2. The residues in the LID domain forming a loop connecting
the two helices of this region have high temperature factors
and poor side chain electron density. This is not surprising
because of the lack of substrates in this structure. A summary
of model statistics is given in Table I.
2 D. Segura-Pen˜a, N. Sekulic, S. Ort, M. Konrad, and A. Lavie, manu-
script in preparation.
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Proline 95 assumes the cis configuration. This proline is
located in a conserved loop sequence motif (hhh92DGh95P96R,
where h stands for bulky hydrophobic) among UMP/CMP ki-
nases and adenylate kinases. In all known structures of adeny-
late and UMP/CMP kinases, this residue was observed in the
cis configuration. The cis proline configuration confers a fold
that enables Asp92 and Arg96 to participate in magnesium
coordination and NMP binding, respectively.
Overall Structure—In an analogous fashion to other NMP
kinases (24), the structure of UMP/CMP kinase has been di-
vided into three regions based on functional and structural
considerations. These are the CORE, NMP-binding. and LID
regions (Fig. 1). The CORE is a rigid part of the protein mole-
cule composed of five parallel -strands (1–5) and helices 1,
5, 6a, 7b, and 8. The P-loop motif responsible for binding
the phosphate groups of the phosphoryl donor nucleotide,
which connects 1 to 1, was assigned as a part of the CORE
region. In the here reported apo-structure, we observed a sul-
fate molecule bound near the P-loop at the position that corre-
sponds to the -phosphate of ATP. This highly conserved loop
undergoes a slight conformational change upon substrate bind-
ing (maximum shift of 1.9 Å in position of the C atom of
Gly11). A change of P-loop conformation in response to the
nature of the nucleotide bound was also observed in thymidy-
late kinase (25, 26), suggesting that P-loop flexibility is a gen-
eral feature in nucleoside monophosphate kinases.
The NMP-binding domain is the part of the molecule that
binds the nucleotide monophosphate (in this case CMP or
UMP) and consists of the three helices 2, 3, and 4 joined by
two short loops. This designation of the NMP-binding region is
different to that previously made based solely on the structure
of the closed conformation of the enzyme, where helix 4 was not
included (7). Our structural comparison of the open and closed
conformation leads to the conclusion that this helix should be
included in the definition of the NMP-binding region because of
its concerted movement with helix 2 (see below).
The LID region is composed of helix 6b followed by a loop
that connects to helix 7a (Fig. 1). Structural studies on several
NMP kinases including UMP/CMP kinase (10) have revealed
that the LID undergoes closure upon binding of substrates,
bringing several catalytic residues in close proximity with the
phosphate groups of both substrates. Although others have
restricted the LID definition to the loop that connects helix 6b
and helix 7a, we include helices 6b and 7a in the LID definition
FIG. 1. Ribbon diagram and sequence alignment of human UMP/CMP kinase. a, ribbon diagram of human UMP/CMP kinase in the open
conformation. Upon substrate binding the relative positions of the LID region (olive), NMP-binding region (gold), and CORE region (blue) change
to form a more compact closed state. The change in conformation is mainly done by rotation of rigid bodies around hinges, labeled I–VI. The sulfate
ion observed bound to the P-loop is shown in green. b, sequence alignment of UMP/CMP kinases with adenylate kinase and guanylate kinase. The
secondary structure elements shown above the alignment are of UMP/CMP kinase. The coloring scheme of the bar below the alignment corresponds
to that used in the ribbon diagram for the individual regions and hinges. All of the structure figures were generated using MOLSCRIPT (37) and
RASTER3D (38).
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for human UMP/CMP kinase because both helices change con-
formation in response to substrate binding. We observed an
analogous behavior in the LID region of mouse guanylate
kinase (27).
Substrate-induced Conformational Change—To identify and
analyze the conformational changes that occur upon substrate
binding in UMP/CMP kinase, we compared the structure of the
human UMP/CMP kinase in the absence of substrate (reported
here) with the structure of the D. discoideum enzyme in com-
plex with ADP, aluminum fluoride, and CMP (10) (Fig. 2). To
rigorously characterize the movements taking place when the
enzyme goes from the open to the closed conformation, three
fitting procedures previously reported by Gerstein and Chothia
(16) were used. These are sieve fit, fit and refit, and fit all (17).
The conformational change that occurs upon substrate bind-
ing is apparent when comparing the structures of the open and
closed states. Overlaying the structures using all atoms results
in the large rmsd of 4.13 Å. In contrast, the rmsd of the 104 C
atoms of the CORE regions is only 0.97 Å. This significant
difference reveals the presence of mobile regions in the protein
molecule.
The overlay based on the CORE region reveals significant
conformational changes in the LID and NMP-binding regions.
In the absence of substrate, the enzyme is in the open confor-
mation characterized by the LID and the NMP-binding regions
being far away from each other. After substrate binding, the
enzyme adopts a more compact conformation that brings the
LID and the NMP-binding region in close proximity (Fig. 2).
For example, the distance between the C atoms of Gly60,
located in helix 3 of the NMP-binding region, and Arg151, lo-
cated in helix 7a of the LID region, shortens from 21 Å in the
open conformation to 4.5 Å in the closed state. Comparing the
positions of C atoms between the two conformations identifies
the residues that move in relationship to the static core (Fig. 3).
The most dramatic movement occurs in the NMP-binding
domain, with a maximum C displacement between the open
and the closed state of 18 Å for the C atom of Glu59. The LID
also undergoes significant movement between the two states.
Here the maximum displacement is 10 Å for the C atom of
Arg140. Interestingly, this residue is one of the LID arginines
that in the closed conformation participates in catalysis by
direct interaction with the transferred phosphoryl group of
ATP (10). The shift of the LID and NMP-binding regions from
the open to the closed form fulfills the criteria of the induced fit
mechanism that calls for catalytic residues to adopt a produc-
tive conformation only after substrate binding.
Conformational Changes of the NMP-binding Region—The
three -helices that make the NMP-binding region cannot be
treated as a single rigid body because helix 3 rotates relative to
helices 2 and 4. Thus, the closure of the NMP-binding region is
due to motion around four separate hinges that we refer to as
hinges I, II, III, and IV (Figs. 1 and 3). The complicated motion
around the four hinges can be dissected into a two-step process
where hinges I and IV, which connect the NMP-binding region
and the CORE, operate on the whole domain, and then hinges
II and III operate on helix 3.
Hinge I is composed of residues 32 and 33 and is located in 
strand 2 at the boundary of the CORE and NMP-binding re-
gions. The movement of hinge I produces a rotation of 11.5° in
helix 2 toward the closed conformation. Analysis of hinge IV is
complicated by the fact that the human UMP/CMP kinase
contains a five-residue insert after helix 4 in comparison with
the D. discoideum enzyme. Therefore, it is not possible to
precisely identify the residues that constitute hinge IV. The
TABLE I
Data collection and refinement statistics
Data collection
X-ray source APS(SER-CAT)1.000Å
Unit cell (Å) a  b  62.8, c  226.6
Space group P6522
Molecules/asymmetric unit 1
















rmsd from ideal geometry (Å)
Bond length 0.015
Angle distances 1.444
Coordinate error (Å) (Luzzati) 0.3
Ramachandran plot statistics (%)
Residues in most favored
regions
94.2
Residues in allowed regions 5.8
Residues in generously allowed
regions
0
Residues in disallowed regions 0
a Rsym I  I;/ I.
b Rcryst Fobs  Fcalc/Fobs. 10% randomly omitted reflections
were used for Rfree.
FIG. 2. Comparing the open and closed conformations of UMP/
CMP kinase. a, ribbon diagram of the UMP/CMP kinase from D.
discoideum in complex with CMP and ADP. b, ribbon diagram of the apo
human UMP/CMP kinase. In both cases, the CORE is colored in blue,
the NMP-binding region is in gold, and the LID is in green. Residues
that belong to hinges are shown in red. c, overlay of apo human UMP/
CMP kinase (red) and the nucleotide-bound D. discoideum UMP/CMP
kinase (green). The superposition matrix used to achieve this overlay
included only atoms from the CORE region. Note the good overlay of the
CORE region but the significant differences in the LID and NMP-
binding regions.
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effect of hinge IV is to rotate helix 4 by 10.9°. This value is very
similar to that observed for hinge I upon helix 2. Therefore, we
conclude that helices 2 and 4 move in a concerted manner. This
conclusion is supported by the fact that superposition of helices
2 and 4 together in the two different structures gives a rmsd of
only 0.32 Å, whereas the overlap of each of the helices individ-
ually with its counterpart in the other structure produces a
relatively similar rmsd. of 0.15 and 0.22 Å for helix 2 and helix
4, respectively. On the other hand, attempting to use the whole
NMP-binding region for the overlay results in a rmsd of 3.5 Å.
Based on this analysis, we were able to model a hypothetical
intermediate structure between the open and the closed state
(Fig. 4). This intermediate structure represents the effects of
hinges I and IV upon closure. When helices 2 and 4 are treated
as a rigid body, a rotation of 11.4° is required to bring the two
helices from the open to the closed state.
Hinges II and III can be seen as hinges within the NMP-
binding region. These internal hinges, which act in unison,
result in a dramatic conformational change in the position of
helix 3 upon closure. Hinge III is composed of residues 65 and
66 that connect helix 3 with helix 4. Hinge II is the most
complex in UMP/CMP kinase. To define the residues of the loop
that form part of the hinge II, we applied the fit all technique
(16). The result of this procedure is presented in the form of a
contour plot (supplemental figure) where regions with a very
steep slope are indicative of residues with significant changes
in the  and  torsion angles. According to the contour plot,
residues 45–51 form hinge II. Interestingly, residues 47 and 48
seem not to contribute to the conformational change, implying
that hinge II is composed of two parts. The overlay of the loop
residues from residues 45 to 51 in the open state with the
equivalent residues in the closed conformation produces a rmsd
of 2.95 Å for a total of only seven amino acids. This poor fitting
is indicative of the significant change in the residue torsion
angles of this region of the enzyme. The combined changes in
the torsion angles of the seven residues in hinge II result in the
dramatic movement of helix 3 characterized by a rotation of
57°. A rotation value of 64° for helix 3 was obtained by using
the program DynDom (28).
It is worth noting that there is good electron density for
hinge II, indicating a well structured loop. A total of six intra-
hinge hydrogen bonds and two interhinge hydrogen bonds (i.e.
residues of hinge II making hydrogen bonds with other parts of
the molecule) act to stabilize this loop. The homology model of
the human UMP/CMP kinase in the closed conformation shows
that even though the hydrogen bonds pairs change after clo-
sure, the total number of hydrogen bond interactions remains
the same.
In summary to this section, we have divided the motion of
the NMP-binding region into two steps. The first one is the
concerted motion around hinges I and IV that moves helices 2
and 4 as a rigid body. The second motion is around hinges II
and III that operates on helix 3, resulting in a dramatic rota-
tion of 57°. The combined effect of hinges I and IV and hinges
II and III on helix 3 is a rotation of 68°. The implication of this
value being equal to the sum of the individual rotational angles
of the two set of hinges (11° from hinges I and IV and 57° from
hinges II and III) is that the two sets of hinges move helix 3 in
the same direction, in an additive manner.
Conformational Changes of the LID Region—The LID region
of most NMP kinases (mammalian thymidylate kinases being a
notable exception (29)) contains several arginines that are cru-
cial for catalysis. Only in the substrate-bound state do these
arginines adopt a conformation that allows a direct interaction
with the phosphates of ATP. The LID of human UMP/CMP
kinase is composed of helix 6b, a loop, and helix 7a. Two hinges
determine the movement in the LID. The first hinge separates
helix 6b from the CORE and is located at residues 128 and 129.
The second hinge separates helix 7a from the CORE and is
located at residues 158 and 159.
The two helices in the LID region move approximately as a
rigid body (rmsd of 0.87 Å for 20 atoms) between the open and
closed form with a total rotation of 18°. However, a more
complicated conformational change for the loop connecting
them is apparent from its poor superposition after applying the
transformation matrix based only on the helices. This implies
the existence of internal hinges that operate on the loop of the
LID region, but because of poor electron density we were not
able to identify these residues with confidence. The described
analysis of motions generated upon substrate binding is de-
picted in a movie (supplemental material).
Substrate Specificity—We were not able to obtain crystals of
UMP/CMP kinase with bound ligand, despite the presence of
substrates (UMP or CMP) or the bisubstrate inhibitor UP5A in
the crystallization buffer. This was rather surprising because
UP5A binds with a dissociation constant in the low nanomolar
range to the human UMP/CMP kinase. The human UMP/CMP
kinase crystallized only at low pH (4.6). Analysis of the crys-
tal packing revealed that the side chain of Asp56 is 2.4 Å away
from the symmetry-related side chain of Asp66. Thus, we con-
clude that the low pH was required to protonate one or both of
these carboxylic acid groups, and only in this state would the
productive crystal contacts be made. However, at this pH, the
binding of substrate and of the inhibitor UP5A could be weak-
ened. One explanation for weak UP5A binding implicates the
lack of ability of the protein to coordinate magnesium at low
pH. UP5A will contribute two phosphate oxygens to ligate this
magnesium, and the other ligands are coming from water mol-
FIG. 3. C-C distance plot. The distance between the position of
C atoms in the open and closed state is depicted as a function of
residue number. The alignment of the enzyme in the two states was
done based on C atoms of the CORE region. The different regions in
the enzyme and the position of hinges are shown above the plot. We set
a threshold of 1 Å between the major moving and the more static
residues (dashed line) because this is close to the rmsd value for atoms
in the CORE region. It is clear from this plot that the most pronounced
conformational change upon substrate binding occurs to the NMP-
binding region and to a lesser but still significant extent to the LID
region. Importantly, residues that belong to the CORE region but that
interact with substrates, such as the P-loop and the magnesium binding
carboxylic acid Asp92, also exhibit observable movement. This implies
that in addition to the major conformational changes observed for the
NMP-binding and LID regions, substrate binding causes conforma-
tional changes of smaller magnitude in residues of the CORE region
that directly interact with the substrate.
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ecules, where one of these water molecules is held in position by
a conserved carboxylic acid (Asp92). However, at low pH, Asp92
will be protonated, abrogating its ability to participate in mag-
nesium binding. In fact, the crystals used to solve the structure
of the slime mold UMP/CMP kinase in complex with UP5A
were grown at pH 8.8 (7); in this condition, the magnesium was
observed. Yet we were unable to obtain crystals of human
UMP/CMP kinase at a higher pH.
As a result, we used the D. discoideum structure to homology
model the human enzyme in the closed conformation. The
purpose was to gain an understanding of the substrate speci-
ficity of the human enzyme (3, 4). Analysis of the model of the
substrate-bound human UMP/CMP kinase reveals a direct in-
teraction between the enzyme and the 2-hydroxyl of the NMP
(2.8 Å between the 2-hydroxyl in ribonucleotides and the car-
bonyl oxygen atom of Lys61) (Fig. 5). This interaction explains
the preference of the enzyme for ribonucleotides over 2-de-
oxyribonucleotides, which is manifested by a higher Km value
of dCMP in comparison with UMP and CMP. Furthermore, the
model rationalizes the high Km of AraCMP for the human
UMP/CMP kinase. Our model predicts that the 2-ara-hydroxyl
group present in this nucleoside analog cannot maintain the
interaction with the carbonyl group of Lys61. The 2-hydroxyl of
AraC, modeled either in the C2-endo conformation, as ob-
served for CMP bound to UMP/CMP kinase (10), or as the
C2-exo, as observed in the deoxycytidine kinase structure (5),
is at a distance between 4.5 and 5.5 Å from the carbonyl group
of Lys61.
The severe reduction in the phosphorylation rate of pyrimi-
dines modified in the 5-position (e.g. TMP versus dUMP) can be
rationalized because of the close contact (3.1 Å) made by the
carbonyl of Gly93 with the base C-5 atom. Furthermore, the
side chain of Ala37 can contribute to the discrimination against
TMP. This observation has implications for the development of
new nucleoside analogs and suggests that even slight modifi-
cations at the 5-position, such as the replacement of a hydrogen
atom with a fluorine, could result in reduced phosphorylation
efficiency. Concerning the phosphoryl donor-binding site, the
preference of the enzyme for ATP (3) becomes evident upon
inspection of the model. In our model, we observe a 2.9 Å
distance between the carbonyl oxygen of Lys179 and the amino
group at the 6-position of the adenine base (Fig. 5a). GTP would
be unfavored because of a carbonyl group at the 6-position.
DISCUSSION
We have obtained the structure of human UMP/CMP kinase
in the absence of substrates (open conformation). Comparison
of the open and the closed states reveals the substrate-induced
conformational changes. The induced fit theory stipulates that
substrates can cause an appreciable change in the conforma-
tion of an enzyme, and as a result of this change, catalytic
residues become correctly positioned to participate in catalysis
(30). Structural studies on NMP kinases have supplied us with
important observations supporting the induced fit theory (31).
The phosphoryl transfer reaction catalyzed by NMP kinases
occurs after the two substrates, phosphoryl acceptor and donor
nucleotides, are bound at the active site. Data support a ran-
dom bi-bi mechanism for this reaction (32), being in contrast to
nucleoside diphosphate kinase that follows a ping-pong mech-
anism. This means that at least four different enzyme confor-
mations can be adopted during the catalytic cycle: a substrate-
free state, two different states in which either the phosphoryl
donor or acceptor nucleotide is bound, and finally, the state in
which both substrates are bound. Unfortunately it has proven
difficult to obtain crystal structures of all of these states on one
particular NMP kinase. Nonetheless, structures of NMP ki-
nases from different species in different states have been ob-
tained. Analysis of these crystal structures made it possible to
create a “movie” displaying possible substrate-induced move-
ments during the reaction (8). In the case of guanylate kinase,
we have recently analyzed similar movements among the apo,
GMP-bound (33), and GMP/ADP-bound states (27). Prior to
this work, all structures of UMP/CMP kinase contained nucle-
otides at both substrate-binding sites. Now having a structure
of the uncomplexed form of human UMP/CMP kinase, we dem-
onstrate that during its catalytic cycle this enzyme experiences
movements similar to those seen in other NMP kinases.
A change in the conformation of hinge residues results in a
rigid body movement of each individual domain relative to the
rigid CORE domain. In contrast to guanylate kinase (27), in the
case of UMP/CMP kinase, in addition to interdomain hinges,
we observe additional hinges that operate within the NMP-
binding and LID regions.
For the LID region, these additional hinges are located in the
loop connecting its adjacent helices. Thus, although the helical
parts of the LID region move as a single rigid body, the loop
part undertakes an additional flipping motion. This side chain
flipping results in 18 Å change in the position of the guani-
dinium moiety of Arg140 between the open and the closed con-
formations, whereas the C atoms difference is 10 Å. Only in
its closed conformation can Arg140 fulfill its catalytic role by
concomitantly interacting with the phosphate of the NMP and
the transferred phosphoryl group of ATP (Fig. 5). Similarly,
FIG. 4. Conformation change in UMP/CMP kinase. Stereo view of UMP/CMP kinase in three states: the open state (red), the closed state
(green), and a hypothetical intermediate state (yellow). This hypothetical state was generated by calculating a transformation matrix between the
open and closed conformations based on helices 2 and 4. The intermediate structure depicts the effects of hinges I and IV on the whole NMP-binding
region. The nucleotides CMP and ADP are depicted in their closed state position. It is evident that both regions act as lids that close around the
substrates upon their binding.
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another catalytically important residue, Arg134, changes its
conformation upon LID closure. Like in the case of Arg140, this
residue can only interact with the transferred phosphoryl
group in the closed conformation. Moreover, the position of
Arg134 in the closed conformation is stabilized by Asp143. The
distance between the side chains of Arg134 and Asp143 de-
creases from 10 Å in the open state to 2.8 Å in the closed state.
The flipping motion of the loop in the LID region is facilitated
by two conserved glycine residues adjacent to the critical
Arg134 and Arg140 (134RGKSSGR140). Support for the interpre-
tation of high loop flexibility of the LID region comes from
analysis by Hutter and Helms (34) of the UMP/CMP kinase
reaction using molecular orbital computations suggesting that
conformational flexibility of the LID region is critical for
catalysis.
The movement observed for the NMP-binding region occurs
via four hinges: two external (I and IV) and two internal (II and
III). The motions of the NMP-binding helix 3, with a total
rotation of 68°, resemble the closure of a lid. As a consequence
of this movement, interactions between residues located in
helix 3 and the phosphoryl acceptor nucleotide (UMP or CMP)
are made possible. Noteworthy is the interaction made by the
2-hydroxyl of the NMP substrate and the carbonyl of Lys61.
This interaction explains the pronounced selectivity for ribo-
nucleotides as evidenced by the 10–60-fold higher Km values
reported for AraCMP as compared with CMP (3, 4). In addition,
hydrophobic interactions with the uridine/cytidine base are
formed in the closed conformation by Leu38, Ile62, and Val63 of
the NMP-binding region.
At the same time the 3-hydroxyl of the sugar interacts with
the LID residue Arg151 in its closed conformation. Thus, the
sugar of the NMP is not only responsible for the stabilization of
the NMP-binding domain in the closed conformation but also in
building a bridge between the LID and NMP-binding domains.
This explains why dCMP, which lacks a 2-hydroxyl, and
ddCMP, which lacks both 2- and 3-hydroxyls, are phosphoryl-
ated with poor efficiency corresponding to only 0.5 and 0.1% of
that of CMP, respectively (3).
However, not all of the residues involved in substrate bind-
ing undergo a dramatic conformational change. For example, in
the case of UMP or CMP binding, the surface made by the
conserved sequence that forms strand 3 and its following loop
changes its conformation only moderately. Asn100, a residue
that plays an important role in the base specificity of UMP/
CMP kinase, is rather static. In addition, Arg96, responsible for
interacting with the UMP or CMP phosphate group, is a part of
the static CORE region. A similar situation occurs at the ATP-
binding site, where certain residues, such as the P-loop (which
binds the  and  phosphates), or Lys179 (which interacts with
the adenine amino group), experience only a slight conforma-
tion change in response to ATP binding. Therefore, these resi-
dues are likely to be required for the initial substrate
recognition.
The current theory postulates that enzymes oscillate be-
tween different low energy states, and the ligands act to stabi-
lize the closed conformation (35, 36). In terms of the induced fit
mechanism, we conclude that the binding sites are partially
formed in the absence of substrates. After the initial substrate-
binding event, which occurs with the enzyme in the open state,
closure of the NMP-binding and LID regions produces addi-
tional contacts with the substrate that stabilize the closed
state. The LID primarily moves as a single rigid body, with an
added flipping motion for the loop that connects the two helices
of the LID region. In contrast, the NMP-binding domain un-
dergoes a pronounced conformational change that can be di-
vided into two distinct motions: an overall rigid body movement
of the whole domain and an additional motion of the central
helix relative to the rest of the domain. Together, these move-
ments of the LID and NMP-binding regions build a catalyti-
cally competent active site. As was previously pointed out (9),
FIG. 5. The substrate-induced con-
formational changes generate a com-
petent active site. Shown is an overlay
of the open UMP/CMP kinase (brown)
and the model of the closed conformation
based on the structure of the D. discoi-
deum enzyme (green). a, focus on the LID
region movements. Only in the conforma-
tion adopted in the presence of both nu-
cleotides (displayed in purple are ADP,
CMP and the aluminum fluoride as ob-
served in the transition state mimic struc-
ture of D. discoideum UMP/CMP kinase
(10)) can the LID arginines 134 and 140
interact with the substrates. Of special
note is the conformational change of
Arg140 that in the closed form allows it to
interact with the AlF3, which corresponds
to the -phosphate of ATP. Additionally,
interactions that position the catalytic
arginines, such as between Arg134 and
Asp143, are only made possible in the
closed state. b, focus on the NMP-binding
region. Only in the closed form is the
UMP/CMP-binding site complete. Here of
special note is the interaction made be-
tween the CMP ribose and the main chain
carbonyl group of Lys61.
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by utilizing the induced fit mechanism NMP kinases can pre-
vent futile ATP hydrolysis by disabling the active center in the
absence of both substrates. Therefore, our results show the
major role played by enzyme dynamics in catalysis and sub-
strate recognition in human UMP/CMP kinase.
Acknowledgments—We thank the staff at SER-CAT (Southeast Re-
gional Collaborative Access Team) for help in data collection.
REFERENCES
1. Van Rompay, A. R., Johansson, M., and Karlsson, A. (1999) Mol. Pharmacol.
56, 562–569
2. Labenz, J., Friedrich, D., and Falke, D. (1982) Arch Virol. 71, 235–249
3. Liou, J. Y., Dutschman, G. E., Lam, W., Jiang, Z., and Cheng, Y. C. (2002)
Cancer Res. 62, 1624–1631
4. Pasti, C., Gallois-Montbrun, S., Munier-Lehmann, H., Veron, M., Gilles, A. M.,
and Deville-Bonne, D. (2003) Eur. J. Biochem. 270, 1784–1790
5. Sabini, E., Ort, S., Monnerjahn, C., Konrad, M., and Lavie, A. (2003) Nat.
Struct. Biol. 10, 513–519
6. Muller-Dieckmann, H. J., and Schulz, G. E. (1994) J. Mol. Biol. 236, 361–367
7. Scheffzek, K., Kliche, W., Wiesmu¨ller, L., and Reinstein, J. (1996) Biochemis-
try 35, 9716–9727
8. Vonrhein, C., Schlauderer, G. J., and Schulz, G. E. (1995) Structure 3, 483–490
9. Muller-Dieckmann, H. J., and Schulz, G. E. (1995) J. Mol. Biol. 246, 522–530
10. Schlichting, I., and Reinstein, J. (1997) Biochemistry 36, 9290–9296
11. Schlichting, I., and Reinstein, J. (1999) Nat. Struct. Biol. 6, 721–723
12. Brundiers, R., Lavie, A., Veit, T., Reinstein, J., Schlichting, I., Ostermann, N.,
Goody, R. S., and Konrad, M. (1999) J. Biol. Chem. 274, 35289–35292
13. Wiesmu¨ller, L., Scheffzek, K., Kliche, W., Goody, R. S., Wittinghofer, A., and
Reinstein, J. (1995) FEBS Lett. 363, 22–24
14. Kabsch, W. (1993) J. Appl. Crystallogr. 24, 795–800
15. Schwede, T., Kopp, J., Guex, N., and Peitsch, M. C. (2003) Nucleic Acids Res.
31, 3381–3385
16. Gerstein, M., and Chothia, C. (1991) J. Mol. Biol. 220, 133–149
17. Lesk, A. M., and Chothia, C. (1984) J. Mol. Biol. 174, 175–191
18. Jones, T. A., Zhou, J.-Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta
Crystallogr. Sect. A 47, 110–119
19. Diamond, R. (1992) Protein Sci. 1, 1279–1287
20. Vagin, A., and Teplyakov, A. (1997) J. Appl. Crystallogr. 30, 1022–1025
21. Perrakis, A., Morris, R., and Lamzin, V. S. (1999) Nat. Struct. Biol. 6, 458–463
22. Dreusicke, D., Karplus, P. A., and Schulz, G. E. (1988) J. Mol. Biol. 199,
359–371
23. Murshudov, G. N., Vagin, A., and Dodson, E. J. (1997) Acta Crystallogr. Sect.
D Biol. Crystallogr. 53, 240–255
24. Schulz, G. E., Mu¨ller, C. W., and Diederichs, K. (1990) J. Mol. Biol. 213,
627–630
25. Ostermann, N., Schlichting, I., Brundiers, R., Konrad, M., Reinstein, J., Veit,
T., Goody, R. S., and Lavie, A. (2000) Struct. Fold. Des. 8, 629–642
26. Ostermann, N., Segura-Pena, D., Meier, C., Veit, T., Monnerjahn, C., Konrad,
M., and Lavie, A. (2003) Biochemistry 42, 2568–2577
27. Sekulic, N., Shuvalova, L., Spangenberg, O., Konrad, M., and Lavie, A. (2002)
J. Biol. Chem. 277, 30236–30243
28. Hayward, S., and Berendsen, H. J. (1998) Proteins 30, 144–154
29. Lavie, A., Vetter, I. R., Konrad, M., Goody, R. S., Reinstein, J., and Schlichting,
I. (1997) Nat. Struct. Biol. 4, 601–604
30. Koshland, D. E. (1994) Angew. Chem. Int. Ed. Engl. 33, 2375–2378
31. Yan, H., and Tsai, M. D. (1999) Adv. Enzymol Relat. Areas Mol. Biol. 73,
103–134
32. Rhoads, D. G., and Lowenstein, J. M. (1968) J. Biol. Chem. 243, 3963–3972
33. Blaszczyk, J., Li, Y., Yan, H., and Ji, X. (2001) J. Mol. Biol. 307, 247–257
34. Hutter, M. C., and Helms, V. (2000) Protein Sci. 9, 2225–2231
35. Kumar, S., Ma, B., Tsai, C. J., Wolfson, H., and Nussinov, R. (1999) Cell
Biochem. Biophys. 31, 141–164
36. Gerstein, M., Lesk, A. M., and Chothia, C. (1994) Biochemistry 33, 6739–6749
37. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946–950
38. Merrit, E. A., and Murphy, M. E. P. (1994) Acta Crystallogr. Sect. D Biol.
Crystallogr. 50, 869–873
Substrate-induced Changes in Human UMP/CMP Kinase 33889
 at M
ax Planck Inst.Biophysikalische Chem
ie,O
tto Hahn Bibl,Pf.2841,37018 G
oettingen on M
arch 23, 2009 
w
w
w
.jbc.org
D
ow
nloaded from
 
